1. Nutrigenomics of FAT: What is “good” or “bad” for human health?Michael MüllerNetherlands Nutrigenomics Centre& Nutrition, Metabolism and Genomics GroupDivision…

1. Metabolic Syndrome and Adipose Tissue Yuji Matsuzawa, MD, PhD Director and Professor Emeritus Osaka University, Sumitomo Hospital, Osaka, Japan 2. A Novel Technique for…

1. Sedentary Behavior and Inactivity Physiology Killing you softly and gently Yannis Guerra Endocrinology Department John H. Stroger Jr. Hospital of Cook County [email_address]…

Slide 1Current issues in co-morbidities and complications Cristina Mussini Slide 2 Source : SHCS 12/2007 Swiss Cohort Study H I V Age distribution of HIV infected individuals…

Slide 1Welcome! Please take a moment to complete the short Please take a moment to complete the short pre-program survey in your packet. Your participation will help us assess…

Slide 1New Concepts in the Evaluation and Treatment of Dyslipidemia Nathan D. Wong, PhD, FACC Professor and Director Heart Disease Prevention Program Division of Cardiology…

Page 1 JL Reny Département de médecine interne CH Béziers « Résistances » aux antiplaquettaires : quelle pertinence clinique ? Page 2 Tuesday, 26 March, 2002, 00:52…

Page 1 1 Intérêt de la Glycémie Post Prandiale dans la prise en charge du Diabète de Type 2 Pr: Hassan EL GHOMARI A Page 2 2 Le Diabète type 2 est caractérisé par…

Slide 1 IPERTENSIONE ARTERIOSA E NEFROPATIA 1) Ruolo nellaumento del rischio cardio vascolare 2) Parametri di valutazione 3) Correlazioni con il profilo metabolico Dott.ssa…

Slide 1 10° international sumposium Heart Failure &Co female doctors speaking on female diseases Milano 9-10 aprile 2010 Thrombosis and coagulation: the Gender Risk…